Skip to main content
Erschienen in: Journal of Gastroenterology 11/2016

29.02.2016 | Original Article—Alimentary Tract

Identification of a serum transglutaminase threshold value for the noninvasive diagnosis of symptomatic adult celiac disease patients: a retrospective study

verfasst von: Marco Di Tola, Mariacatia Marino, Simone Goetze, Rossella Casale, Sara Di Nardi, Raffaele Borghini, Giuseppe Donato, Antonio Tiberti, Antonio Picarelli

Erschienen in: Journal of Gastroenterology | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

A celiac disease (CD) diagnosis is based on duodenal histology, with the exception of children showing anti-tissue transglutaminase (anti-tTG) serum levels exceeding ten times the cut-off. Our aim was to reproduce this simplified approach in adults, identifying an anti-tTG threshold value useful to diagnose CD without endoscopic procedures.

Methods

A total of 671 adult CD patients were subjected to blood sampling to determine anti-tTG serum levels, as well as to endoscopy with biopsy to perform duodenal histology. The anti-tTG serum levels/cut-off ratio was compared with the degree of duodenal lesions.

Results

Anti-tTG serum levels/cut-off ratio determined in patients with type IIIc was significantly higher than that measured in patients with type IIIb (p < 0.001), IIIa (p < 0.001), II (p < 0.05) and 0 (p < 0.001) of Marsh–Oberhuber histological classification. A significant correlation (r = 0.297, p < 0.0001) was found between the anti-tTG serum levels/cut-off ratio and the degree of duodenal lesions. The anti-tTG serum levels/cut-off ratio was classified as an accurate parameter (AUC = 0.715, p < 0.0001), with the best diagnostic performance obtained considering the threshold value >3.6 (sensitivity = 76.8 %, PPV = 97.2 %).

Conclusions

The anti-tTG serum levels/cut-off ratio correlates with the degree of duodenal lesions and, if used with the threshold value >3.6, could avoid endoscopy with biopsy in about 75 % of seropositive adults waiting for CD diagnosis. However, since this procedure could also imply CD diagnosis in almost 3 % of seropositive patients with normal villous architecture, a consensus opinion is needed to suggest its use in the diagnosis of adult CD.
Literatur
1.
Zurück zum Zitat Green PH, Lebwohl B, Greywoode R. Celiac disease. J Allergy Clin Immunol. 2015;135:1099–106.CrossRefPubMed Green PH, Lebwohl B, Greywoode R. Celiac disease. J Allergy Clin Immunol. 2015;135:1099–106.CrossRefPubMed
2.
Zurück zum Zitat Abadie V, Sollid LM, Barreiro LB, et al. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol. 2011;29:493–525.CrossRefPubMed Abadie V, Sollid LM, Barreiro LB, et al. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol. 2011;29:493–525.CrossRefPubMed
3.
4.
Zurück zum Zitat Volta U, Granito A, Parisi C, et al. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol. 2010;44:186–90.CrossRefPubMed Volta U, Granito A, Parisi C, et al. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol. 2010;44:186–90.CrossRefPubMed
5.
Zurück zum Zitat Di Sabatino A, Vanoli A, Giuffrida P, et al. The function of tissue transglutaminase in celiac disease. Autoimmun Rev. 2012;11:746–53.CrossRefPubMed Di Sabatino A, Vanoli A, Giuffrida P, et al. The function of tissue transglutaminase in celiac disease. Autoimmun Rev. 2012;11:746–53.CrossRefPubMed
6.
Zurück zum Zitat Kang JY, Kang AH, Green A, et al. Systematic review: worldwide variation in the frequency of celiac disease and changes over time. Aliment Pharmacol Ther. 2013;38:226–45.CrossRefPubMed Kang JY, Kang AH, Green A, et al. Systematic review: worldwide variation in the frequency of celiac disease and changes over time. Aliment Pharmacol Ther. 2013;38:226–45.CrossRefPubMed
7.
Zurück zum Zitat Walker-Smith JA, Guandalini S, Schmitz J. Revised criteria for diagnosis of celiac disease. Arch Dis Child. 1990;65:909–11.CrossRef Walker-Smith JA, Guandalini S, Schmitz J. Revised criteria for diagnosis of celiac disease. Arch Dis Child. 1990;65:909–11.CrossRef
8.
Zurück zum Zitat Oberhuber G, Granditsch G, Vogelsang H. The histopathology of celiac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185–94.CrossRefPubMed Oberhuber G, Granditsch G, Vogelsang H. The histopathology of celiac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185–94.CrossRefPubMed
9.
Zurück zum Zitat Husby S, Koletzko S, Korponay-Szabó IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of celiac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–60.CrossRefPubMed Husby S, Koletzko S, Korponay-Szabó IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of celiac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–60.CrossRefPubMed
10.
Zurück zum Zitat Ludvigsson JF, Bai JC, Biagi F, et al. Diagnosis and management of adult celiac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;63:1210–28.CrossRefPubMedPubMedCentral Ludvigsson JF, Bai JC, Biagi F, et al. Diagnosis and management of adult celiac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;63:1210–28.CrossRefPubMedPubMedCentral
11.
12.
Zurück zum Zitat Meeuwisse GW. Diagnostic criteria in celiac disease. Acta Paediatr Scand. 1970;58:461–3. Meeuwisse GW. Diagnostic criteria in celiac disease. Acta Paediatr Scand. 1970;58:461–3.
13.
Zurück zum Zitat Fabiani E. Catassi C; International Working Group. The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow up of celiac disease. Results of an international multi-centre study. International Working Group on Eu-tTG. Eur J Gastroenterol Hepatol. 2001;13:659–65.CrossRefPubMed Fabiani E. Catassi C; International Working Group. The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow up of celiac disease. Results of an international multi-centre study. International Working Group on Eu-tTG. Eur J Gastroenterol Hepatol. 2001;13:659–65.CrossRefPubMed
14.
Zurück zum Zitat Diamanti A, Colistro F, Calce A, et al. Clinical value of immunoglobulin A antitransglutaminase assay in the diagnosis of celiac disease. Pediatrics. 2006;118:e1696–700.CrossRefPubMed Diamanti A, Colistro F, Calce A, et al. Clinical value of immunoglobulin A antitransglutaminase assay in the diagnosis of celiac disease. Pediatrics. 2006;118:e1696–700.CrossRefPubMed
15.
Zurück zum Zitat Barker CC, Mitton C, Jevon G, et al. Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations? Pediatrics. 2005;115:1341–6.CrossRefPubMed Barker CC, Mitton C, Jevon G, et al. Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations? Pediatrics. 2005;115:1341–6.CrossRefPubMed
16.
Zurück zum Zitat Vivas S, Ruiz de Morales JG, Riestra S, et al. Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World J Gastroenterol. 2009;15:4775–80.CrossRefPubMedPubMedCentral Vivas S, Ruiz de Morales JG, Riestra S, et al. Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World J Gastroenterol. 2009;15:4775–80.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Mubarak A, Wolters VM, Gerritsen SA, et al. A biopsy is not always necessary to diagnose celiac disease. J Pediatr Gastroenterol Nutr. 2011;52:554–7.CrossRefPubMed Mubarak A, Wolters VM, Gerritsen SA, et al. A biopsy is not always necessary to diagnose celiac disease. J Pediatr Gastroenterol Nutr. 2011;52:554–7.CrossRefPubMed
18.
Zurück zum Zitat Hill P, Austin A, Forsyth J, et al. British Society of Gastroenterology guidelines on the diagnosis and management of celiac disease. Gut. 2015;64:691–2.CrossRefPubMed Hill P, Austin A, Forsyth J, et al. British Society of Gastroenterology guidelines on the diagnosis and management of celiac disease. Gut. 2015;64:691–2.CrossRefPubMed
19.
Zurück zum Zitat Tortora R, Imperatore N, Capone P, et al. The presence of anti-endomysial antibodies and the level of anti-tissue transglutaminases can be used to diagnose adult celiac disease without duodenal biopsy. Aliment Pharmacol Ther. 2014;40:1223–9.CrossRefPubMed Tortora R, Imperatore N, Capone P, et al. The presence of anti-endomysial antibodies and the level of anti-tissue transglutaminases can be used to diagnose adult celiac disease without duodenal biopsy. Aliment Pharmacol Ther. 2014;40:1223–9.CrossRefPubMed
20.
Zurück zum Zitat Bürgin-Wolff A, Mauro B, Faruk H. Intestinal biopsy is not always required to diagnose celiac disease: a retrospective analysis of combined antibody tests. BMC Gastroenterol. 2013;13:19.CrossRefPubMedPubMedCentral Bürgin-Wolff A, Mauro B, Faruk H. Intestinal biopsy is not always required to diagnose celiac disease: a retrospective analysis of combined antibody tests. BMC Gastroenterol. 2013;13:19.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Malamut G, Cellier C. Complications of celiac disease. Best Pract Res Clin Gastroenterol. 2015;29:451–8.CrossRefPubMed Malamut G, Cellier C. Complications of celiac disease. Best Pract Res Clin Gastroenterol. 2015;29:451–8.CrossRefPubMed
22.
Zurück zum Zitat Taavela J, Kurppa K, Collin P, et al. Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease. Clin Gastroenterol Hepatol. 2013;11:166–71.CrossRefPubMed Taavela J, Kurppa K, Collin P, et al. Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease. Clin Gastroenterol Hepatol. 2013;11:166–71.CrossRefPubMed
23.
Zurück zum Zitat Singh P, Kurray L, Agnihotri A, et al. Titers of anti-tissue transglutaminase antibody correlate well with severity of villous abnormalities in celiac disease. J Clin Gastroenterol. 2015;49:212–7.CrossRefPubMed Singh P, Kurray L, Agnihotri A, et al. Titers of anti-tissue transglutaminase antibody correlate well with severity of villous abnormalities in celiac disease. J Clin Gastroenterol. 2015;49:212–7.CrossRefPubMed
24.
Zurück zum Zitat Sugai E, Hwang HJ, Vázquez H, et al. Should ESPGHAN guidelines for serologic diagnosis of celiac disease be used in adults? A prospective analysis in an adult patient cohort with high pretest probability. Am J Gastroenterol. 2015;110:1504–5.CrossRefPubMed Sugai E, Hwang HJ, Vázquez H, et al. Should ESPGHAN guidelines for serologic diagnosis of celiac disease be used in adults? A prospective analysis in an adult patient cohort with high pretest probability. Am J Gastroenterol. 2015;110:1504–5.CrossRefPubMed
25.
Zurück zum Zitat Picarelli A, Di Tola M, Sabbatella L, et al. Identification of a new celiac disease subgroup: antiendomysial and anti-transglutaminase antibodies of IgG class in the absence of selective IgA deficiency. J Intern Med. 2001;249:181–8.CrossRefPubMed Picarelli A, Di Tola M, Sabbatella L, et al. Identification of a new celiac disease subgroup: antiendomysial and anti-transglutaminase antibodies of IgG class in the absence of selective IgA deficiency. J Intern Med. 2001;249:181–8.CrossRefPubMed
27.
Zurück zum Zitat Picarelli A, Di Tola M, Sabbatella L, et al. Anti-tissue transglutaminase antibodies in arthritic patients: a disease-specific finding? Clin Chem. 2003;49:2091–4.CrossRefPubMed Picarelli A, Di Tola M, Sabbatella L, et al. Anti-tissue transglutaminase antibodies in arthritic patients: a disease-specific finding? Clin Chem. 2003;49:2091–4.CrossRefPubMed
28.
Zurück zum Zitat Di Tola M, Sabbatella L, Anania MC, et al. Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Clin Chem Lab Med. 2004;42:1092–7.CrossRefPubMed Di Tola M, Sabbatella L, Anania MC, et al. Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Clin Chem Lab Med. 2004;42:1092–7.CrossRefPubMed
29.
Zurück zum Zitat Di Tola M, Barillà F, Trappolini M, et al. Antitissue transglutaminase antibodies in acute coronary syndrome: an alert signal of myocardial tissue lesion? J Intern Med. 2008;263:43–51.CrossRefPubMed Di Tola M, Barillà F, Trappolini M, et al. Antitissue transglutaminase antibodies in acute coronary syndrome: an alert signal of myocardial tissue lesion? J Intern Med. 2008;263:43–51.CrossRefPubMed
30.
Zurück zum Zitat Picarelli A, Di Tola M, Sabbatella L, et al. Usefulness of the organ culture system in the in vitro diagnosis of celiac disease: a multicentre study. Scand J Gastroenterol. 2006;41:186–90.CrossRefPubMed Picarelli A, Di Tola M, Sabbatella L, et al. Usefulness of the organ culture system in the in vitro diagnosis of celiac disease: a multicentre study. Scand J Gastroenterol. 2006;41:186–90.CrossRefPubMed
31.
Zurück zum Zitat Santaolalla R, Fernández-Bañares F, Rodríguez R, et al. Diagnostic value of duodenal antitissue transglutaminase antibodies in gluten-sensitive enteropathy. Aliment Pharmacol Ther. 2008;27:820–9.CrossRefPubMed Santaolalla R, Fernández-Bañares F, Rodríguez R, et al. Diagnostic value of duodenal antitissue transglutaminase antibodies in gluten-sensitive enteropathy. Aliment Pharmacol Ther. 2008;27:820–9.CrossRefPubMed
32.
Zurück zum Zitat Tosco A, Aitoro R, Auricchio R, et al. Intestinal anti-tissue transglutaminase antibodies in potential celiac disease. Clin Exp Immunol. 2013;171:69–75.CrossRefPubMed Tosco A, Aitoro R, Auricchio R, et al. Intestinal anti-tissue transglutaminase antibodies in potential celiac disease. Clin Exp Immunol. 2013;171:69–75.CrossRefPubMed
33.
Zurück zum Zitat Picarelli A, Di Tola M, Marino M, et al. Usefulness of the organ culture system when villous height/crypt depth ratio, intraepithelial lymphocyte count, or serum antibody tests are not diagnostic for celiac disease. Transl Res. 2013;161:172–80.CrossRefPubMed Picarelli A, Di Tola M, Marino M, et al. Usefulness of the organ culture system when villous height/crypt depth ratio, intraepithelial lymphocyte count, or serum antibody tests are not diagnostic for celiac disease. Transl Res. 2013;161:172–80.CrossRefPubMed
Metadaten
Titel
Identification of a serum transglutaminase threshold value for the noninvasive diagnosis of symptomatic adult celiac disease patients: a retrospective study
verfasst von
Marco Di Tola
Mariacatia Marino
Simone Goetze
Rossella Casale
Sara Di Nardi
Raffaele Borghini
Giuseppe Donato
Antonio Tiberti
Antonio Picarelli
Publikationsdatum
29.02.2016
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 11/2016
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-016-1188-y

Weitere Artikel der Ausgabe 11/2016

Journal of Gastroenterology 11/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.